Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Invested Capital (2021 - 2022)

Historic Return on Invested Capital for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Invested Capital changed 0.0% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.19% for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Return on Invested Capital is 0.05%, which was down 0.0% from 0.02% recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.19% for Q4 2021, and its period low was 0.02% during Q2 2022.